Report Information More information from: https://www.wiseguyreports.com/reports/456549
Next generation cancer diagnostics - Global Market Outlook (20152022) Report / Search Code: WGR456549
Price
1-user PDF : $ 4150.0
Description:
Publish Date: 1 March, 2016
1-5 User PDF : $ 5250.0
Enterprise PDF : $ 7500.0
According to Stratistics MRC, the Global Next Generation Cancer Diagnostics market is estimated at $2.95 billion in 2015 and is expected to grow at a CAGR of 32.6% to reach $20.93 billion by 2022. Growing incidence of oncology diseases is expected to boost the demand for next generation cancer diagnostic tests market. However, lack of sufficient reimbursement policies for novel technologies and stringent regulatory procedures are the major factors that can hamper the global next generation cancer diagnostics market growth over the forecast period. The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia Pacific is likely to be one of the fastest growing regions of this sector and is anticipated to grow at a lucrative rate. A largely untouched market base which has exhibited technological advancements in healthcare research during the past decade is responsible for rapid growth in this region. Some of the key players in the global Next Generation Cancer Diagnostics market are Thermo Fisher Scientific, Inc., Roche, Philips Electronics NV, Perkin Elmer Inc., Novartis AG, Lab-on-achip, Illumina, Inc., Agilent Technologies Inc, Siemens Healthcare, Johnson & Johnson, Hologic Inc., GE Healthcare, C.R. Bard, Inc and Abbot. Cancer Type Covered: • Lung Cancer • Colorectal Cancer • Cervical Cancer • Breast Cancer • Other Cancer Types Functions Covered: • Therapeutic Monitoring • Risk analysis • Prognostics diagnosis • Companion Diagnostics • Cancer Screening Technologies Covered: • Platform-Based Diagnostics o Polymerase Chain Reaction (PCR) o Next-Generation Sequencing (NGS) o Microarrays o In Situ Hybridization (ISH) o Immunohistochemistry (IHC) o Flow Cytometry o Other Technologies • Instrument-Based o Diagnostic Imaging o Ultrasound o Mammography • Biopsies Regions Covered: • North America o US o Canada o Mexico • Europe o Germany
o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
Contents:
1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Application Analysis 3.7 Technology Analysis 3.8 Emerging markets 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global Next Generation Cancer Diagnostics Market, By Application 5.1 Introduction 5.2 Proteomic Analysis
5.3 Epigenetic Analysis 5.4 Genetic Analysis 5.5 Biomarker Development 5.6 CTC Analysis 6 Global Next Generation Cancer Diagnostics Market, By Technology 6.1 Introduction 6.2 Lab-on-a-chip 6.3 DNA Microarrays 6.4 Multiplexed assays 6.5 RT-PCR & Multiplexing 6.6 Protein Microarrays 6.7 Cellular capture and identification 6.8 Next Generation Sequencing 6.9 Benchtop Sequencers 6.10 Other Technologies 7 Global Next Generation Cancer Diagnostics Market, By Function 7.1 Introduction 7.2 Prognosis Diagnostics 7.3 Companion Diagnostics 7.4 Cancer Screening 7.5 Risk Analysis 7.6 Therapeutic Monitoring 8 Global Next Generation Cancer Diagnostics Market, By Cancer Type 8.1 Introduction 8.2 Sex-related tumors 8.2.1 Cervical Cancer 8.2.2 Breast Cancer 8.2.3 Ovarian Cancer 8.2.4 Prostate Cancer 8.3 Blood-born cancers 8.3.1 Myeloma 8.3.2 Leukemia 8.3.3 Lymphoma 8.4 Lung Cancer 8.5 Solid tumors 8.6 Colorectal Cancer 8.7 Other Cancers 9 Global Next Generation Cancer Diagnostics Market, By Geography 9.1 North America 9.1.1 US 9.1.2 Canada 9.1.3 Mexico 9.2 Europe 9.2.1 Germany 9.2.2 France 9.2.3 Italy 9.2.4 UK 9.2.5 Spain 9.2.6 Rest of Europe 9.3 Asia Pacific 9.3.1 Japan 9.3.2 China 9.3.3 India 9.3.4 Australia 9.3.5 New Zealand 9.3.6 Rest of Asia Pacific 9.4 Rest of the World 9.4.1 Middle East 9.4.2 Brazil 9.4.3 Argentina 9.4.4 South Africa 9.4.5 Egypt 10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling 11.1 Abbott Laboratories 11.2 Agilent Technologies Inc 11.3 GE Healthcare 11.4 Genomic Health Inc. 11.5 Hologic Inc. 11.6 Illumina Inc. 11.7 Johnson & Johnson 11.8 Myriad Genetics Inc. 11.9 Novartis AG 11.10 Opko Health Inc. 11.11 Perkin Elmer Inc. 11.12 Philips Electronics NV 11.13 Qiagen 11.14 Roche Holding AG 11.15 Thermo Fisher Scientific Inc. List of Tables 1 Global Next Generation Cancer Diagnostics Market Outlook, By Region (2013-2022) ($MN) 2 Global Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN) 3 Global Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN) 4 Global Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN) 5 Global Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN) 6 Global Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (20132022) ($MN) 7 Global Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN) 8 Global Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN) 9 Global Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN) 10 Global Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN) 11 Global Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (20132022) ($MN) 12 Global Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (20132022) ($MN) 13 Global Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (20132022) ($MN) 14 Global Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN) 15 Global Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN) 16 Global Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (20132022) ($MN) 17 Global Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (20132022) ($MN) 18 Global Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN) 19 Global Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (20132022) ($MN) 20 Global Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (20132022) ($MN) 21 Global Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN) 22 Global Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN) 23 Global Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (20132022) ($MN) 24 Global Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN)
25 Global Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (20132022) ($MN) 26 Global Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN) 27 Global Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN) 28 Global Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN) 29 Global Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN) 30 Global Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (20132022) ($MN) 31 Global Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN) 32 Global Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN) 33 Global Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN) 34 Global Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN) 35 Global Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN) 36 Global Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN) 37 Global Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN) 38 North America Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN) 39 North America Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN) 40 North America Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN) 41 North America Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (20132022) ($MN) 42 North America Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN) 43 North America Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (20132022) ($MN) 44 North America Next Generation Cancer Diagnostics Market Outlook, By Technology (20132022) ($MN) 45 North America Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (20132022) ($MN) 46 North America Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN) 47 North America Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN) 48 North America Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN) 49 North America Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN) 50 North America Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN) 51 North America Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN) 52 North America Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN) 53 North America Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN) 54 North America Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN) 55 North America Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN) 56 North America Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN) 57 North America Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN) 58 North America Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (20132022) ($MN) 59 North America Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN) 60 North America Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-
2022) ($MN) 61 North America Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN) 62 North America Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (20132022) ($MN) 63 North America Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (20132022) ($MN) 64 North America Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (20132022) ($MN) 65 North America Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (20132022) ($MN) 66 North America Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN) 67 North America Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN) 68 North America Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN) 69 North America Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN) 70 North America Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (20132022) ($MN) 71 North America Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (20132022) ($MN) 72 North America Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN) 73 North America Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (20132022) ($MN) 74 Europe Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN) 75 Europe Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (20132022) ($MN) 76 Europe Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (20132022) ($MN) 77 Europe Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN) 78 Europe Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN) 79 Europe Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN) 80 Europe Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN) 81 Europe Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN) 82 Europe Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN) 83 Europe Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (20132022) ($MN) 84 Europe Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (20132022) ($MN) 85 Europe Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (20132022) ($MN) 86 Europe Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN) 87 Europe Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN) 88 Europe Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (20132022) ($MN) 89 Europe Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (20132022) ($MN) 90 Europe Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN) 91 Europe Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (20132022) ($MN) 92 Europe Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (20132022) ($MN) 93 Europe Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN) 94 Europe Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN) 95 Europe Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-
2022) ($MN) 96 Europe Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN) 97 Europe Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (20132022) ($MN) 98 Europe Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN) 99 Europe Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN) 100 Europe Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN) 101 Europe Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN) 102 Europe Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (20132022) ($MN) 103 Europe Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN) 104 Europe Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN) 105 Europe Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN) 106 Europe Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN) 107 Europe Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN) 108 Europe Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (20132022) ($MN) 109 Europe Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN) 110 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Application (2013-2022) ($MN) 111 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN) 112 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN) 113 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (20132022) ($MN) 114 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN) 115 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (20132022) ($MN) 116 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Technology (2013-2022) ($MN) 117 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (20132022) ($MN) 118 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (20132022) ($MN) 119 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN) 120 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN) 121 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN) 122 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN) 123 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN) 124 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN) 125 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN) 126 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Function (2013-2022) ($MN) 127 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN) 128 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Companion Diagnostics (2013-2022) ($MN) 129 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (20132022) ($MN) 130 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-
2022) ($MN) 131 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN) 132 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN) 133 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN) 134 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (20132022) ($MN) 135 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (20132022) ($MN) 136 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (20132022) ($MN) 137 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (20132022) ($MN) 138 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN) 139 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Myeloma (2013-2022) ($MN) 140 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Leukemia (2013-2022) ($MN) 141 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (2013-2022) ($MN) 142 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN) 143 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (2013-2022) ($MN) 144 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (20132022) ($MN) 145 Asia Pacific Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (20132022) ($MN) 146 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Application (20132022) ($MN) 147 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Proteomic Analysis (2013-2022) ($MN) 148 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Epigenetic Analysis (2013-2022) ($MN) 149 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Genetic Analysis (2013-2022) ($MN) 150 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Biomarker Development (2013-2022) ($MN) 151 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By CTC Analysis (2013-2022) ($MN) 152 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Technology (20132022) ($MN) 153 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lab-on-a-chip (2013-2022) ($MN) 154 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By DNA Microarrays (2013-2022) ($MN) 155 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Multiplexed assays (2013-2022) ($MN) 156 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By RT-PCR & Multiplexing (2013-2022) ($MN) 157 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Protein Microarrays (2013-2022) ($MN) 158 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cellular capture and identification (2013-2022) ($MN) 159 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Next Generation Sequencing (2013-2022) ($MN) 160 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Benchtop Sequencers (2013-2022) ($MN) 161 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Other Technologies (2013-2022) ($MN) 162 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Function (20132022) ($MN) 163 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Prognosis Diagnostics (2013-2022) ($MN) 164 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Companion
Diagnostics (2013-2022) ($MN) 165 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cancer Screening (2013-2022) ($MN) 166 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Risk Analysis (2013-2022) ($MN) 167 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Therapeutic Monitoring (2013-2022) ($MN) 168 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cancer Type (2013-2022) ($MN) 169 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Sex-related tumors (2013-2022) ($MN) 170 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Cervical Cancer (2013-2022) ($MN) 171 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Breast Cancer (2013-2022) ($MN) 172 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Ovarian Cancer (2013-2022) ($MN) 173 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Prostate Cancer (2013-2022) ($MN) 174 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Blood-born cancers (2013-2022) ($MN) 175 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Myeloma (20132022) ($MN) 176 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Leukemia (20132022) ($MN) 177 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lymphoma (20132022) ($MN) 178 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Lung Cancer (2013-2022) ($MN) 179 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Solid tumors (20132022) ($MN) 180 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Colorectal Cancer (2013-2022) ($MN) 181 Rest of the World Next Generation Cancer Diagnostics Market Outlook, By Other Cancers (2013-2022) ($MN)
wiseguyreports.com / Phone (US) + 1-646-845-9349 (UK) +44 208 133 9349